
Aria CV, Inc.
Aria CV is a medical device company developing a novel implantable device designed to treat pulmonary hypertension.
/10
Transparency ranking
Work at Aria CV, Inc.?
Tell us what we're missing about working at Aria CV, Inc. so we can make the job search more transparent for everyone.
Tell us what it's like to work at Aria CV, Inc.!Description
Aria CV, Inc. is a medical device company based in St. Paul, Minnesota, focused on developing a novel implantable device to treat Pulmonary Hypertension (PH). Founded in 2010, the company was established by Drs. John Scandurra and Karl Vollmers, who invented the technology during their fellowship at the University of Minnesota's Earl E. Bakken Medical Devices Center. Aria CV's device aims to restore compliance to the pulmonary vessels by mimicking the function of healthy arteries, thereby reducing the workload on the heart and potentially improving exercise capacity while reducing the risk of right heart failure.
Aria CV has secured funding from major investors such as Xeraya Capital, Catalyst Health Ventures, and Broadview Ventures, and has received FDA Breakthrough Designation for its medical device. The company has successfully completed an acute first-in-human clinical study in Vienna, Austria, and continues to develop its technology through ongoing clinical trials. Aria CV is committed to advancing its innovative device and bringing a potential breakthrough treatment to patients suffering from PH.
Mission
Aria CV, Inc. is a medical device company focused on developing a novel implantable device to treat pulmonary hypertension (PH). Their mission is to improve the lives of patients with PH by developing a minimally invasive device that restores compliance to the pulmonary vessels, enabling the heart to pump more blood with less energy. Their technology aims to reduce the burden on the heart and improve exercise capacity for patients suffering from this serious and life-limiting disease.
Culture
Aria CV promotes a culture of innovation, collaboration, and dedication to improving the lives of patients with pulmonary hypertension. The company's website highlights its strong team of scientists, engineers, and clinicians who are passionate about developing a breakthrough treatment for this serious condition. Their commitment to research and development is evident in their pursuit of patents and clinical trials, while their emphasis on transparency and communication is reflected in their comprehensive website with detailed information about their technology, team, and progress.
DE&I
Aria CV, Inc. does not explicitly state its approach to diversity, equity, and inclusion on its website.
Similar companies. But verified.
